Red wine decreases asymmetric dimethylarginine via SIRT1 induction in human endothelial cells

Biochemical and Biophysical Research Communications

Volumn 390, Issue 3, 2009, Pages 703-709

  Scalera, Fortunato ^a   Fulge, Birthe ^a   Martens Lobenhoffer, Jens ^a   Heimburg, Anke ^b   Bode Böger, Stefanie M ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b IMTM GmbH   (Germany)

Author keywords

Asymmetric dimethylarginine; Dimethylarginine dimethylaminohydrolase; Endothelial cells; Oxidative stress; Red wine; SIRT1

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; DIMETHYLARGININASE; DIMETHYLARGININE DIMETHYLAMINOHYDROLASE II; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE SYNTHASE; PEROXYNITRITE; PROTEIN ARGININE METHYLTRANSFERASE; PROTEIN ARGININE METHYLTRANSFERASE 1; PROTEIN P53; SIRTUIN 1; UNCLASSIFIED DRUG;

ARTICLE; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; METABOLISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RED WINE; UPREGULATION;

AGE FACTORS; AGING; AMIDOHYDROLASES; ARGININE; CELL AGING; CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; METHYLTRANSFERASES; NITRIC OXIDE SYNTHASE; SIRTUIN 1; UP-REGULATION; WINE;

VITACEAE;

EID: 70449701441     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.10.033     Document Type: Article

References (37)

1. Renaud S., and de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339 (1992) 1523-1526
2. Szmitko P.E., and Verma S. Antiatherogenic potential of red wine: clinician update. Am. J. Physiol. Heart Circ. Physiol. 288 (2005) H2023-H2030
3. Opie L.H., and Lecour S. The red wine hypothesis: from concepts to protective signalling molecules. Eur. Heart J. 28 (2007) 1683-1693
4. Wallerath T., Poleo D., Li H., and Förstermann U. Red wine increases the expression of human endothelial nitric oxide synthase. J. Am. Coll. Cardiol. 41 (2003) 471-478
5. Corder R., Douthwaite J.A., Less D.M., Khan N.Q., Viseu Dos Santos A.C., Wood E.G., and Carrier M.J. Endothelin-1 synthesis reduced by red wine. Nature 414 (2001) 863-864
6. Pignatelli P., Ghiselli A., Buchetti B., Carnevale R., Natella F., Germanò G., Fimognari F., Di Santo S., Lenti L., and Violi F. Polyphenols synergistically inhibit oxidative stress in subjects given red and white wine. Atherosclerosis 188 (2006) 77-83
7. Napoli C., Balestrieri M.L., Sica V., Lerman L.O., Crimi E., De Rosa G., Schiano C., Servillo L., and D'Armiento F.P. Beneficial effects of low doses of red wine consumption on perturbed shear stress-induced atherogenesis. Heart Vessels 23 (2008) 124-133
8. Mukherjee S., Lekli I., Gurusamy N., Bertelli A.A.A., and Das D.K. Expression of the longevity proteins by both red and white wines and their cardioprotective components, resveratrol, tyrosol, and hydroxytyrosol. Free Radic. Biol. Med. 46 (2009) 573-578
9. +, sirtuins, and cardiovascular disease. Curr. Pharm. Des. 15 (2009) 110-117
10. Lavu S., Boss O., Elliot P.J., and Lambert P.D. Sirtuins-novel therapeutic targets to treat age associated diseases. Nat. Rev. Drug. Discov. 7 (2008) 841-853
11. Ota H., Akishita M.M., Eto M., Iijima K., Kaneki M., and Ouchi Y. Sirt1 modulates premature senescence-like phenotype in human endothelial cells. J. Mol. Cell. Cardiol. 43 (2007) 571-579
12. Ota H., Eto M., Kano M.R., Ogawa S., Iijima K., Akishita M., and Ouchi Y. Cilostazol inhibits oxidative stress-induced premature senescence via upregulation of Sirt1 in human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 28 (2008) 1634-1639
13. Minamino T., and Komuro I. Vascular cell senescence: contribution to atherosclerosis. Circ. Res. 100 (2007) 15-26
14. Bode-Böger S.M., Martens-Lobenhoffer J., Täger M., Schröder H., and Scalera F. Aspirin reduces endothelial cell senescence. Biochem. Biophys. Res. Commun. 334 (2005) 1226-1232
15. Scalera F., Martens-Lobenhoffer J., Bukowska A., Lendeckel U., Täger M., and Bode-Böger S.M. Effect of telmisartan on nitric oxide-asymmetric dimethylarginine system. Role of angiotensin II type 1 receptor and peroxisome proliferator activated receptor γ signaling during endothelial aging. Hypertension 51 (2008) 696-703
16. Scalera F., Borlak J., Beckmann B., Martens-Lobenhoffer J., Thum T., Täger M., and Bode-Böger S.M. Endogenous nitric oxide synthesis inhibitor asymmetric dimetlyl l-arginine accelerates endothelial cell senescence. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 1816-1822
17. Antoniades C., Shirodaria C., Leeson P., Antonopoulos A., Warrick N., Van-Assche T., Cunnington C., Tousoulis D., Pillai R., Ratnatunga C., Stefanadis C., and Channon K.M. Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis. Eur. Heart J. 30 (2009) 1142-1150
18. Bode-Böger S.M., Scalera F., and Ignarro L.J. The l-arginine paradox: importance of the l-arginine/asymmetrical dimethylarginine ratio. Pharmcol. Ther. 114 (2007) 295-306
19. Miyazaki H., Matsuoka H., Cooke J.P., Usui M., Ueda S., Okuda S., and Imaizumi T. Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Circulation 99 (1999) 1141-1146
20. Kielstein J.T., Bode-Böger S.M., Frölich J.C., Ritz E., Haller H., and Fliser D. Asymmetrical dimethylarginine, blood pressure, and renal perfusion in elderly subjects. Circulation 107 (2003) 1891-1895
21. Böger R.H., Sullivan L.M., Schwedhelm E., Wang T.J., Maas R., Benjamin E.J., Schulze F., Xanthakis V., Benndorf R.A., and Vasan R.S. Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community. Circulation 119 (2009) 1592-1600
22. Scalera F., Kielstein J., Martens-Lobenhoffer J., Postel S., Täger M., and Bode-Böger S.M. Erythropoietin increases asymmetric dimethylarginine in endothelial cells-role of dimethylarginine dimethylaminohydrolase. J. Am. Soc. Nephrol. 16 (2005) 892-898
23. Martens-Lobenhoffer J., and Bode-Böger S.M. Fast and efficient determination of arginine, symmetric dimethylarginine, and asymmetric dimethylarginine in biological fluids by hydrophilic-interaction liquid chromatography-electrospray tandem mass spectrometry. Clin. Chem. 42 (2006) 488-493
24. Scalera F., Closs E.I., Flick E., Martens-Lobenhoffer J., Boissel J.P., Lendeckel U., Heimburg A., and Bode-Böger S.M. Paradoxical effect of l-arginine: acceleration of endothelial cell senescence. Biochem. Biophys. Res. Commun. 386 (2009) 650-655
25. Scalera F., Martens-Lobenhoffer J., Täger M., Bukowska A., Lendeckel U., and Bode-Böger S.M. Effect of l-arginine on asymmetric dimethylarginine (ADMA) or homocysteine-accelerated endothelial cell aging. Biochem. Biophys. Res. Commun. 345 (2006) 1075-1082
26. Balestrieri M.L., Schiano C., Felice F., Casamassimi A., Balestrieri A., Milone L., Servillo L., and Napoli C. Effect of low doses of red wine and pure resveratrol on circulating endothelial progenitor cells. J. Biochem. 43 (2008) 179-186
27. Wallenborg K., Vlachos P., Eriksson S., Huijbregts L., Arnér E.S.J., Joseph B., and Hermanson O. Red wine triggers cell death and thioredoxin reductase inhibition: effects beyond resveratrol and SIRT1. Exp. Cell. Res. 315 (2009) 1360-1371
28. Goldberg D.M., Yan J., Ng E., Diamandis E.P., Karumanchiri A., Soleas G., and Waterhouse A.L. A global survey of trans-resveratrol concentrations in commercial wines. Am. J. Enol. Vitic. 46 (1995) 159-165
29. Böger R.H., Sydow K., Borlak J., Thum T., Lenzen H., Schubert B., Tsikas D., and Bode-Böger S.M. LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells. Involvement of S-adenosylmethionine-dependent methyltransferases. Circ. Res. 87 (2000) 99-105
30. Cooke J.P. Asymmetrical dimethylarginine. The über marker?. Circulation 109 (2004) 1813-1819
31. Leiper J.M., Santa Maria J., Chubb A., MacAllister R.J., Charles I.G., Whitley G.S., and Vallance P. Identification of two human diemthylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases. Biochem. J. 343 (1999) 209-214
32. Murray-Rust J., Leiper J., McAlister M., Phelan J., Tilley S., Santa Maria J., Vallance P., and McDonald N. Structural insights into the hydrolysis of cellular nitric oxide synthase inhibitors by dimethylarginine dimethylaminohydrolase. Nat. Struct. Biol. 8 (2001) 679-683
33. Dávalos A., de la Pena G., Sanchez-Martin C.C., Teresa Guerra M., Bartolome B., and Lasuncion M.A. Effect of red grape juice polyphenols in NADPH oxidase subunit express ion in human neutrophils and mononuclear blood cells. Br. J. Nutr. 19 (2009) 1-11
34. Marfella R., Cacciapuoti F., Siniscalchi M., Sasso F.C., Marchese F., Cinone F., Musacchio E., Marfella M.A., Ruggiero L., Chiorazzo G., Liberti D., Chiorazzo D., Nicoletti G.F., Saron C., D'Andrea F., Ammendola C., Verza M., and Coppola L. Effect of moderate red wine intake on cardiac prognosis after recent acute myocardial infarction of subjects with type 2 diabetes mellitus. Diabet. Med. 23 (2006) 974-981
35. Micallef M., Lexis L., and Lewandowski P. Red wine consumption increases antioxidant status and decreases oxidative stress in the circulation of both young and old humans. Nutr. J. 6 (2007) 27
36. Kume S., Haneda M., Kanasaki K., Sugimoto T., Araki S., Isono M., Isshiki K., Uzu T., Kashiwagi A., and Koya D. Silent information regulator 2 (SIRT1) attenuates oxidative stress-induced mesangial cell apoptosis via p53 deacetylation. Free Radic. Biol. Med. 40 (2006) 2175-2182
37. Orimo M., Minamino T., Miyauchi H., Tateno K., Okada S., Moriya K., Okada S., Moriya J., and Komuro I. Protective role of SIRT1 in diabetic vascular dysfunction. Arterioscler. Thromb. Vasc. Biol. 29 (2009) 889-894